Dr. Julie Chen, Chief Medical Officer at Radence, outlines the use of genomic precision medicine and advanced biomarkers and imaging technology for early detection and diagnosis of disease, with a focus on extending the health span, not just the lifespan, of their clients. This comprehensive membership-based model aggregates members' health data to create a 360° view of their health risks. AI is a critical tool for identifying trends in longitudinal data, enabling more accurate and personalized health monitoring for both those who are healthy and those recovering from an existing condition.

Julie explains, "Our model is a membership-based model primarily because a lot of the leading-edge technology is not insurance-covered. And so we're able to then utilize what is necessary for the diagnosis and the management, and actionable steps for the members, without having to worry about what insurance will or will not cover."

"Our members come through, and we actually aggregate all of their outside medical records and data because we want to see what their baseline health has been up to the point that they join us as a member. And then at that point, we actually get from the cellular level all the way up to the organ level and functionality level, we start to aggregate information about their genomics, so the blueprint of who they are health-wise."

"The key focus here is really looking at the concept that longevity is a larger picture phrase that has been in this industry, used across the board for a lot of different things. That could encompass biohacking, to true evidence-based genomic precision medicine, to just trends of what people are using. So I think it's really important for your listeners to understand that longevity is theoretically in the category of what we're doing in that space, but the very important point is to really look at the space, as there are a lot of things on the market now."

#Radence #GenomicMedicine #PrecisionMedicine #EarlyDetection #HealthSpan #Longevity #AIinHealthcare #PreventiveCare

Radence.com

Listen to the podcast here